{
  "id": "everyday#risk_safety_f39e06e4",
  "title_en": "General — Risk Safety",
  "title_vi": "General — Nguy cơ An toàn",
  "text_en": "Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders PSY7. In adults with bipolar disorder (current episode mania), are antipsychotic medicines and mood stabilizers effective and safe? Recommendation (update): 7.1 Oral antipsychotic medicines (namely aripiprazole, haloperidol, olanzapine, paliperidone or quetiapine) or mood stabilizers (namely carbamazepine, lithium, valproic acid [sodium valproate]) should be offered to adults with bipolar disorder (current episode mania), carefully balancing effectiveness, side-effects and individual preference. Strength of recommendation: Strong Certainty of evidence: Low 7.2 Valproic acid (sodium valproate) should not be used in women and girls of childbearing potential owing to the high risk of birth defects and neurodevelopmental disorders in babies in utero. Strength of recommendation: Strong Certainty of evidence: Low Justification QT prolongation, sedation, which all appear in y Data were extracted from an NMA: Kishi et al., 2022 varying degrees. (included 72 RCTs on pharmacological treatment for y According to the systematic review used, the mood bipolar mania) (202). stabilizers which were effective – carbamazepine, y In the review, the antipsychotics aripiprazole, sodium valproate and lithium – have important asenapine, cariprazine, haloperidol, olanzapine, side-effects as well. Rare, but extremely serious paliperidone, quetiapine, risperidone side-effects are that carbamazepine is associated and ziprasidone and the mood stabilizers with the risk of Stevens-Johnson syndrome and toxic carbamazepine, lithium and sodium valproate epidermal necrolysis (203). outperformed placebo significantly for the outcome y An important side-effect of sodium valproate is response to treatment. The effect sizes were small its teratogenic potential. It significantly increases to moderate. the risk of malformations such as neural tube y The review used for this PICO question only defects and cleft palate at birth (204). The addressed the global tolerability outcome, European Medical Agency (EMA) recommends “discontinuation due to adverse effects”. With avoiding sodium valproate in pregnancy and that regard to the outcome discontinuation due to it should not be used in the absence of pregnancy adverse effects, the antipsychotics asenapine and prevention programmes. For mania, teratogenicity haloperidol and the mood stabilizer lithium had is problematic as the condition leads to impaired significantly higher discontinuation rates than judgement and an increase in risky promiscuous placebo. Effect sizes were small to moderate. No behaviour (205). review that addressed specific side-effects of single y Lithium has a very narrow therapeutic window agents was identified. The side-effects of various beyond which",
  "gloss_vi": "Mental health gap action programme (mhgap) guideline for mental, neurological and substance use disorders psy7. in adults with bipolar disorder (current episode mania), are antipsychotic medicines and mood stabilizers ef...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "risk_safety",
      "referral",
      "do_not_do"
    ],
    "life_topics": [],
    "advice_section": [],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Risk Safety General — Nguy cơ An toàn Mental Health Gap Action Programme (mhGAP) guideline for mental, neurological and substance use disorders PSY7. In adults with bipolar disorder (current episode mania), are antipsychotic medicines and mood stabilizers effective and safe? Recommendation (update): 7.1 Oral antipsychotic medicines (namely aripiprazole, haloperidol, olanzapine, paliperidone or quetiapine) or mood stabilizers (namely carbamazepine, lithium, valproic acid [sodium valproate]) should be offered to adults with bipolar disorder (current episode mania), carefully balancing effectiveness, side-effects and individual preference. Strength of recommendation: Strong Certainty of evidence: Low 7.2 Valproic acid (sodium valproate) should not be used in women and girls of childbearing potential owing to the high risk of birth defects and neurodevelopmental disorders in babies in utero. Strength of recommendation: Strong Certainty of evidence: Low Justification QT prolongation, sedation, which all appear in y Data were extracted from an NMA: Kishi et al., 2022 varying degrees. (included 72 RCTs on pharmacological treatment for y According to the systematic review used, the mood bipolar mania) (202). stabilizers which were effective – carbamazepine, y In the review, the antipsychotics aripiprazole, sodium valproate and lithium – have important asenapine, cariprazine, haloperidol, olanzapine, side-effects as well. Rare, but extremely serious paliperidone, quetiapine, risperidone side-effects are that carbamazepine is associated and ziprasidone and the mood stabilizers with the risk of Stevens-Johnson syndrome and toxic carbamazepine, lithium and sodium valproate epidermal necrolysis (203). outperformed placebo significantly for the outcome y An important side-effect of sodium valproate is response to treatment. The effect sizes were small its teratogenic potential. It significantly increases to moderate. the risk of malformations such as neural tube y The review used for this PICO question only defects and cleft palate at birth (204). The addressed the global tolerability outcome, European Medical Agency (EMA) recommends “discontinuation due to adverse effects”. With avoiding sodium valproate in pregnancy and that regard to the outcome discontinuation due to it should not be used in the absence of pregnancy adverse effects, the antipsychotics asenapine and prevention programmes. For mania, teratogenicity haloperidol and the mood stabilizer lithium had is problematic as the condition leads to impaired significantly higher discontinuation rates than judgement and an increase in risky promiscuous placebo. Effect sizes were small to moderate. No behaviour (205). review that addressed specific side-effects of single y Lithium has a very narrow therapeutic window agents was identified. The side-effects of various beyond which Mental health gap action programme (mhgap) guideline for mental, neurological and substance use disorders psy7. in adults with bipolar disorder (current episode mania), are antipsychotic medicines and mood stabilizers ef..."
}